A comprehensive view of Regeneron Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

U.S. Patent and Trademark Office Receives Regeneron Pharmaceuticals's Patent Application for Vegf Traps and Mini-Traps and Methods for Treating Ocular Disorders and Cancer
Published: April 22, 2024 by Pharmaceutical Patent News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS FOR REDUCING ALLOANTIBODY LEVELS IN SUBJECTS IN NEED OF SOLID ORGAN TRANSPLANTATION"
Published: April 22, 2024 by U.S. Fed News
Patent Issued for Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein (USPTO 11944666)
Published: April 22, 2024 by NewsRx Cardiovascular Daily
Patent Issued for Anti-ACVR1 antibodies and uses thereof (USPTO 11945872)
Published: April 22, 2024 by NewsRx Hematology Daily
Australia: Regeneron Pharmaceuticals, Sanofi Biotechnology Receive Patent for 'Compositions for the treatment of rheumatoid arthritis and methods of using same'
Published: April 19, 2024 by Australian Government

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count